Effect of genetic polymorphisms on the interplay of P-glycoprotein transporter and cytochrome P450 enzymes: Pharmacokinetics of risperidone

Effect of genetic polymorphisms on the interplay of P-glycoprotein transporter and cytochrome P450 enzymes: Pharmacokinetics of risperidone

Bibliographic Details
Main Author:	Yong-Bok Lee
Format:	Article
Language:	English
Published:	Elsevier 2016-02-01
Series:	Asian Journal of Pharmaceutical Sciences
Subjects:	Genetic polymorphism ABCB1 CYP2D6 Risperidone Population pharmacokinetics
Online Access:	http://www.sciencedirect.com/science/article/pii/S181808761500121X

Similar Items

Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects
by: Ji Min Han, et al.
Published: (2020-05-01)

Effect of cytochrome P450 3A5 polymorphism on the pharmacokinetics of tacrolimus in renal transplant recipients
by: Yi Yi Htun, et al.
Published: (2020-03-01)

Effects of resveratrol on P-glycoprotein and cytochrome P450 3A in vitro and on pharmacokinetics of oral saquinavir in rats
by: Li JP, et al.
Published: (2016-11-01)

CYP2D6 polymorphisms and their influence on risperidone treatment
by: Puangpetch A, et al.
Published: (2016-12-01)

Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone
by: Jinjun Lu, et al.
Published: (2021-02-01)

Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin
by: Gonzalo Villapalos-García, et al.
Published: (2021-10-01)

Naringenin alters the pharmacokinetics of ranolazine in part through the inhibition of cytochrome P450 (3A4) and P-glycoprotein
by: Faisal Alotaibi
Published: (2023-03-01)

External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data
by: Eleni Karatza, et al.
Published: (2022-03-01)

CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People
by: Yuanxia Cui, et al.
Published: (2020-08-01)

Exploratory focused pharmacogenetic testing reveals novel markers associated with risperidone pharmacokinetics in Saudi children with autism
by: Sireen Abdul Rahim Shilbayeh, et al.
Published: (2024-02-01)

Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients
by: Xiaoyi Wang, et al.
Published: (2024-01-01)

Testing the Pharmacokinetic Interactions of 24 Colonic Flavonoid Metabolites with Human Serum Albumin and Cytochrome P450 Enzymes
by: Violetta Mohos, et al.
Published: (2020-03-01)

Polymorphism in Cytochrome P450 3A4 Is Ethnicity Related
by: Yelena Guttman, et al.
Published: (2019-03-01)

Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance
by: Usman Nawaz, et al.
Published: (2023-11-01)

Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility
by: Meng Li, et al.
Published: (2019-08-01)

Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes
by: Mouhrach I, et al.
Published: (2023-10-01)

Effect of Ticagrelor, a Cytochrome P450 3A4 Inhibitor, on the Pharmacokinetics of Tadalafil in Rats
by: Young-Guk Na, et al.
Published: (2019-07-01)

In vitro study on the effect of peucedanol on the activity of cytochrome P450 enzymes
by: Cun Zhang, et al.
Published: (2021-01-01)

In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes
by: Yang Li, et al.
Published: (2020-01-01)

Genetic Polymorphism of Cytochrome p450 (2C19) Enzyme in Iranian Turkman Ethnic Group
by: Robabeh Ghiyas Tabari, et al.
Published: (2013-07-01)

Impact of Cytochromes P450 3A4 and 2B6 gene polymorphisms on predisposition and prognosis of acute myeloid leukemia: an Egyptian case-control study
by: Shahira Kamal Anis Botros, et al.
Published: (2021-04-01)

Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone
by: Simeon Rüdesheim, et al.
Published: (2022-08-01)

The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro
by: Xu RA, et al.
Published: (2018-11-01)

Effect of P450 Oxidoreductase Polymorphisms on the Metabolic Activities of Ten Cytochrome P450s Varied by Polymorphic CYP Genotypes in Human Liver Microsomes
by: Yan Fang, et al.
Published: (2018-06-01)

Preparation and in vivo evaluation of a gel-based nasal delivery system for risperidone
by: Gu Fugen, et al.
Published: (2016-12-01)

Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors
by: Natchaya Vanwong, et al.
Published: (2020-11-01)

In vitro inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes
by: Ning Zhang, et al.
Published: (2019-01-01)

In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes
by: Gang Dong, et al.
Published: (2018-01-01)

In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes
by: Xunge Zhang, et al.
Published: (2020-01-01)

Polymorphisms of Cytochrome P450 Genes in Three Ethnic Groups from Russia
by: Elena Viktorova, et al.
Published: (2012-09-01)

Polymorphism of the cytochrome P-450 1A1 (A2455G) in women with breast cancer in Eastern Azerbaijan, Iran
by: Hakimeh Saadatian, et al.
Published: (2014-03-01)

<i>CYP3A5*3</i> and <i>CYP3A4*22</i> Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach
by: Zeyar Mohammed Ali, et al.
Published: (2023-11-01)

Inhibitory activity of sesaminol and sesaminol triglycoside on cytochrome P450 enzymes and their pharmacokinetics in rats
by: Kuo-Ching Jan, et al.
Published: (2014-03-01)

Interactions of Mycotoxin Alternariol with Cytochrome P450 Enzymes and OATP Transporters
by: Eszter Fliszár-Nyúl, et al.
Published: (2022-12-01)

Genetic Polymorphisms of Cytochromes P450 in Finno-Permic Populations of Russia
by: Murat Dzhaubermezov, et al.
Published: (2022-12-01)

In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes
by: Jinlan Wei, et al.
Published: (2018-01-01)

Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs
by: Léa Darnaud, et al.
Published: (2023-03-01)

Terbinafine and risperidone drug interaction contributing to clinical changes in a forensic psychiatric patient
by: Reynolds Jamie PharmD, et al.
Published: (2023-06-01)

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study
by: Walling DP, et al.
Published: (2021-10-01)

Cytochrome P450c17alpha (CYP17) gene polymorphism is not associated with leiomyoma susceptibility
by: Hsieh Yao-Yuan, et al.
Published: (2002-01-01)